Home/Wockhardt/Dr. Zoher Sihorwala
DZ

Dr. Zoher Sihorwala

Senior Vice President and Head – Drug Regulatory Affairs

Wockhardt

Wockhardt Pipeline

DrugIndicationPhase
Zaynich (WCK 5222)cUTI, HABP/VABP caused by MDR Gram-negative bacteriaNDA Filed
WCK 5153Resistant Gram-negative infectionsPhase I
ZoliflodacinUncomplicated GonorrheaPhase III
WCK 4282Resistant Hospital-Acquired InfectionsPreclinical/Phase I
Biosimilar Insulin GlargineDiabetes MellitusLaunched
Biosimilar Insulin AspartDiabetes MellitusLaunched